ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 43, Pages E6669-E6678
Publisher
Proceedings of the National Academy of Sciences
Online
2016-10-12
DOI
10.1073/pnas.1603876113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
- (2015) R. Pagliarini et al. EMBO REPORTS
- Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense
- (2015) Angelo D’Alessandro et al. Oncotarget
- Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells
- (2014) Akinori Morita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting antioxidants for cancer therapy
- (2014) Andrea Glasauer et al. BIOCHEMICAL PHARMACOLOGY
- Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations
- (2014) F. Alvarez-Calderon et al. CLINICAL CANCER RESEARCH
- Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?
- (2014) Keith W. Pratz et al. CURRENT OPINION IN HEMATOLOGY
- New strategies for relapsed acute myeloid leukemia
- (2014) Shira N. Dinner et al. CURRENT OPINION IN HEMATOLOGY
- Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
- (2014) Mark Levis Future Oncology
- The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)
- (2014) Brian B. Hasinoff et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synergistic Anti-Cancer Effect of Phenformin and Oxamate
- (2014) W. Keith Miskimins et al. PLoS One
- Glutathione and mitochondria
- (2014) Vicent Ribas et al. Frontiers in Pharmacology
- Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
- (2013) Ju-Yoon Yoon et al. APOPTOSIS
- Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
- (2013) M. Ambrose et al. BLOOD
- Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells
- (2013) Shanshan Pei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Large-scale gene function analysis with the PANTHER classification system
- (2013) Huaiyu Mi et al. Nature Protocols
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
- (2012) R Swords et al. LEUKEMIA
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
- (2012) Ronald K. Blackman et al. PLoS One
- Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
- (2012) Dania Daye et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A ROS rheostat for cell fate regulation
- (2012) Maria Maryanovich et al. TRENDS IN CELL BIOLOGY
- Mitochondrial dysfunction in ataxia-telangiectasia
- (2011) Y. A. Valentin-Vega et al. BLOOD
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
- (2011) Marko Škrtić et al. CANCER CELL
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome
- (2010) Federico V. Pallardó et al. BIOGERONTOLOGY
- Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
- (2010) Mark A. Gregory et al. CANCER CELL
- ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair
- (2010) Claudia Cosentino et al. EMBO JOURNAL
- The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt
- (2010) Y. Li et al. MOLECULAR CANCER THERAPEUTICS
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
- (2010) A. Alexander et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATM Activation by Oxidative Stress
- (2010) Z. Guo et al. SCIENCE
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
- (2009) Georg T. Wondrak ANTIOXIDANTS & REDOX SIGNALING
- Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells
- (2009) Jelena Klawitter et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- A Targetable Fluorescent Probe for Imaging Hydrogen Peroxide in the Mitochondria of Living Cells
- (2008) Bryan C. Dickinson et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
- Deregulation of Signaling Pathways in Acute Myeloid Leukemia
- (2008) Claudia Scholl et al. SEMINARS IN ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started